Inventor profile of:

Terence O'Reilly

City:

Basel

Country:

Switzerland

Published Applications:

18

Last publication date:

2014-04-17

Top Assignees for applications by Terence O'Reilly

The entities that hold a legal rights for patent applications filed by inventor O'Reilly Terence:

Recent patent applications by O'Reilly Terence

Terence O'Reilly from Basel, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2014-04-17
US20140105895A1
Human necessities

TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES

#2 | 2013-11-07
US20130296359A1
Human necessities

TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES

#3 | 2013-10-31
US20130287769A1
Human necessities

Treatment of solid tumors with rapamycin derivatives

#4 | 2013-09-26
US20130253000A1
Human necessities

TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES

#5 | 2013-09-19
US20130244951A1
Human necessities

TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES

#6 | 2013-04-02
US10468520
-

Cancer treatment

#7 | 2013-03-07
US20130059877A1
Human necessities

TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES

#8 | 2012-11-08
US20120283285A1
Human necessities

Treatment of solid tumors with rapamycin derivatives

#9 | 2012-11-08
US20120283206A1
Human necessities

Combination comprising N--4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent.

#10 | 2012-08-23
US20120214774A1
Human necessities

Treatment of solid tumors with rapamycin derivatives

#11 | 2010-05-25
US10469367
-

Combination comprising a signal transduction inhibitor and an epothilone derivative

#12 | 2009-08-13
US20090202541A1
Human necessities

COMBINATION COMPRISING N-{5-[4-(4-METHYL-PIPERAZINO-METHYL)-BENZOYLAMIDO]-2-METHYLPHENYL)-4-(3-PYRIDYL)-2PYRIMIDINE-AMINE AND A CHEMOTHERAPEUTIC AGENT

#13 | 2009-01-08
US20090012105A1
Human necessities

Combination of Mtor Inhibitor and Antipolate Compound

#14 | 2008-08-28
US20080207565A1
Human necessities

USE OF BISPHOSPHONATES FOR PAIN TREATMENT

#15 | 2008-08-14
US20080194613A1
Physics

p53 wild-type as biomarker for the treatment with mTOR inhibitors in combination with a cytotoxic agent

#16 | 2007-07-19
US20070167478A1
Physics

Biomarkers for sensitivity of proliferative diseases to mtor inhibitors

#17 | 2006-10-05
US20060223867A1
Human necessities

Cancer treatment with epothilones

#18 | 2005-07-28
US20050165071A1
Human necessities

Cancer treatment with epothilones

InventorID:

129095 ⎘